Anirban Roychowdhury
Overview
Explore the profile of Anirban Roychowdhury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kapadia B, Roychowdhury A, Kayastha F, Lee W, Nanaji N, Windle J, et al.
Neoplasia
. 2025 Feb;
62:101144.
PMID: 39987653
Epitranscriptomic modifications, particularly N6-methyladenosine (m6A), have emerged as critical regulators of RNA stability, localization, and translation, shaping immune responses and tumor progression. In B-cell biology, m6A modifications influence germinal center...
2.
Pal D, Samadder S, Dutta P, Roychowdhury A, Chakraborty B, Dutta S, et al.
Pathol Res Pract
. 2023 Jul;
248:154696.
PMID: 37516000
Cervical carcinoma (CACX) is still a dreadful threat to women in developing countries. Available conventional chemo-radiation therapies are not sufficient to restrict the disease recurrence. To unravel the mechanism of...
3.
Roychowdhury A, Pal D, Basu M, Samadder S, Mondal R, Roy A, et al.
Cell Signal
. 2023 May;
109:110735.
PMID: 37257769
Purpose: Cervical Squamous Cell Carcinoma (CSCC) is one of the significant causes of cancer deaths among women. Distinct genetic and epigenetic-altered loci, including chromosomal 11p15.5-15.4, have been identified. CDKN1C (Cyclin-Dependent...
4.
Kayastha F, Herrington N, Kapadia B, Roychowdhury A, Nanaji N, Kellogg G, et al.
Mol Med
. 2022 Sep;
28(1):101.
PMID: 36058921
Background: Deregulated translation initiation is implicated extensively in cancer initiation and progression. It is actively pursued as a viable target that circumvents the dependency on oncogenic signaling, a significant factor...
5.
Roychowdhury A, Basu M, Pal D, Dutta P, Samadder S, Mondal R, et al.
J Genet
. 2022 Jul;
101.
PMID: 35791609
Squamous cell carcinoma of the uterine cervix (CSCC) is one of the leading causes of death in Indian women. Protein tyrosine phosphatase receptor (PTPR) type J (also known as DEP1)...
6.
Maitra S, Chatterjee M, Roychowdhury A, Panda C, Sinha S, Mukhopadhyay K
Mol Biol Rep
. 2022 May;
49(8):7315-7325.
PMID: 35553330
Background: Impulsivity (Imp), being one of the cardinal symptoms of Attention Deficit Hyperactivity Disorder (ADHD), often leads to inappropriate responses to stimuli. Since the dopaminergic system is the primary target...
7.
Kapadia B, Roychowdhury A, Kayastha F, Nanaji N, Gartenhaus R
Mol Cancer Res
. 2022 Feb;
PMID: 35191952
Patients with high-risk diffuse large B-cell lymphoma (DLBCL) have poor outcomes following first-line cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab (R-CHOP); thus, treatment of this fatal disease remains an area of...
8.
Kapadia B, Roychowdhury A, Kayastha F, Nanaji N, Gartenhaus R
Mol Cancer Res
. 2022 Feb;
PMID: 35105670
Patients with high-risk diffuse large B-cell lymphoma (DLBCL) have poor outcomes following first-line cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab (R-CHOP); thus, treatment of this fatal disease remains an area of...
9.
Roychowdhury A, Jondhale M, Saldanha E, Ghosh D, Panda C, Chandrani P, et al.
Gene
. 2021 May;
792:145728.
PMID: 34022297
TNBC is the most aggressive and hormone receptor-negative subtype of breast cancer with molecular heterogeneity in bulk tumors hindering effective treatment. Toll-like receptors (TLRs) have the potential to ignite diverse...
10.
Chakraborty B, Mukhopadhyay D, Roychowdhury A, Basu M, Alam N, Chatterjee K, et al.
Med Microbiol Immunol
. 2020 Nov;
210(1):49-63.
PMID: 33226516
The aim of this study is to understand the association of HPV infection and wnt-β-catenin self-renewal pathway in development of head and neck squamous cell carcinoma (HNSCC). For this reason,...